Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.97 -34.49 -0.83%
Ticker Volume Price Price Delta
STOXX 50 3,175.97 -23.72 -0.74%
FTSE 100 6,674.74 -7.02 -0.11%
DAX 9,544.19 -55.90 -0.58%
Ticker Volume Price Price Delta
NIKKEI 14,545.29 -0.98 -0.01%
TOPIX 1,173.11 -0.70 -0.06%
HANG SENG 22,527.38 17.74 0.08%

Infinity to Participate in Three Upcoming Conferences



  Infinity to Participate in Three Upcoming Conferences

Business Wire

CAMBRIDGE, Mass. -- November 6, 2013

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in three
upcoming investor conferences. Infinity will provide an overview of its
business at the following conferences:

  * Credit Suisse 2013 Healthcare Conference, Phoenix, AZ, November 13, 2013,
    9:00 a.m. MT (11:00 a.m. ET)
  * 2013 Deutsche Bank BioFEST, Boston, MA, December 2, 2013, 10:10 a.m. ET

Additionally, on November 21, 2013, Infinity will participate in meetings at
RBC Capital Markets’ Denver Healthcare Investor Day in Denver, CO.

Live audio webcasts of Infinity’s presentations at the Credit Suisse and
Deutsche Bank conferences will be accessible from the “Investors/Media”
section of the company’s website, www.infi.com, and replays will be available
for 30 days following each event.

About Infinity Pharmaceuticals, Inc.
Infinity is an innovative biopharmaceutical company dedicated to discovering,
developing and delivering best-in-class medicines to people with
difficult-to-treat diseases. Infinity combines proven scientific expertise
with a passion for developing novel small molecule drugs that target emerging
disease pathways. For more information on Infinity, please refer to the
company’s website at www.infi.com.

Contact:

Infinity Pharmaceuticals, Inc.
Jaren Madden, 617-453-1336
Jaren.Madden@infi.com
http://www.infi.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement